SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-009473
Filing Date
2022-03-10
Accepted
2022-03-10 07:06:57
Documents
77
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K srra-10k_20211231.htm   iXBRL 10-K 3466905
2 EX-4.4 srra-ex44_148.htm EX-4.4 47354
3 EX-10.5 srra-ex105_234.htm EX-10.5 677182
4 EX-23.1 srra-ex231_10.htm EX-23.1 2287
5 EX-31.1 srra-ex311_9.htm EX-31.1 9911
6 EX-31.2 srra-ex312_14.htm EX-31.2 9906
7 EX-32.1 srra-ex321_7.htm EX-32.1 6279
8 EX-32.2 srra-ex322_11.htm EX-32.2 6160
  Complete submission text file 0001564590-22-009473.txt   12277284

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA srra-20211231.xsd EX-101.SCH 67086
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20211231_cal.xml EX-101.CAL 61217
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20211231_def.xml EX-101.DEF 240933
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20211231_lab.xml EX-101.LAB 533026
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20211231_pre.xml EX-101.PRE 400811
71 EXTRACTED XBRL INSTANCE DOCUMENT srra-10k_20211231_htm.xml XML 2214033
Mailing Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404
Business Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404 (605) 376-8679
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37490 | Film No.: 22727374
SIC: 2834 Pharmaceutical Preparations